Markets › United States › NAS › IART

Integra Lifesciences Holdings Corp

NAS:IARTHealthcareCBOEFTSE:MRUTNASDAQ:NCX

$13.33−0.89%At closeAt close · Wed 21 Oct · ≈ AED 48.95 · Market cap $1.04B · Next earnings Wed 21 Oct

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	62.0%	61.2%	62.3%	57.4%	54.8%	51.7%	—	—
Operating margin	11.0%	12.8%	15.3%	7.2%	1.8%	4.2%	4.2%	+0.0 pts
Net margin	9.8%	11.0%	11.6%	4.4%	−0.4%	−31.6%	−31.6%	+0.0 pts
EBITDA margin	19.5%	23.7%	24.7%	16.6%	12.0%	−19.9%	—	—
Return on equity	8.8%	10.0%	10.0%	4.3%	−0.4%	−49.5%	−49.5%	+0.0 pts
Return on assets	3.7%	4.5%	4.6%	1.8%	−0.2%	−14.3%	−14.3%	+0.0 pts
Return on capital employed	4.7%	5.7%	6.7%	3.2%	0.9%	2.2%	—	—
Debt / equity	1.1×	1.0×	0.9×	1.1×	1.3×	1.9×	1.9×	+0.0%
Debt / assets	45.8%	44.0%	41.9%	44.5%	49.2%	56.4%	—	—
Interest coverage	2.1×	3.9×	4.8×	2.2×	0.4×	0.8×	—	—
Current ratio	3.1×	3.4×	3.6×	3.4×	1.2×	2.5×	2.5×	+0.0%
Quick ratio	2.3×	2.5×	2.6×	2.2×	0.7×	1.5×	—	—
Cash ratio	1.2×	1.5×	1.4×	0.9×	0.3×	0.5×	0.5×	+0.0%
Asset turnover	0.4×	0.4×	0.4×	0.4×	0.4×	0.5×	—	—
Inventory turnover	1.7×	1.9×	1.8×	1.7×	1.7×	1.6×	—	—
Receivables turnover	6.1×	6.3×	5.9×	5.9×	5.9×	5.9×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—